"At OHC, our search for new treatments is relentless. Our drive to provide superior care runs deep. And our fight against cancer is personal. Our independent, physician-led practice is known for delivering clinical excellence combined with unmatched personal and emotional support in neighborhoods throughout the region. OHC has been fighting cancer on the front lines for more than 35 years. We are the region’s premier source of treatment for nearly every form of adult cancer and complex blood disorder. At its heart, our approach to cancer care is simple – to surround you with everything you need so you can focus on what matters most: beating cancer."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
36
SWOG Cancer Research Network
20
Alliance for Clinical Trials in Oncology
11
ECOG-ACRIN Cancer Research Group
6
Gynecologic Oncology Group
3
GOG Foundation
2
Eastern Cooperative Oncology Group
1
NRG Oncology
1
Clinical Trials at Oncology Hematology Care Inc-Mercy West
During the past decade, Oncology Hematology Care Inc-Mercy West conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 50 clinical trials were completed, i.e. on
average, 208.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 32 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
2011-04-01
2023-07-01
Active, not recruiting
1,545
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Oncology Hematology Care Inc-Mercy West" #1 sponsor was "National Cancer Institute (NCI)" with 36 trials, followed by "SWOG Cancer Research Network" with 20 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "Gynecologic Oncology Group"
with 6 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Hematology Care Inc-Mercy West"
#1 collaborator was "National Cancer Institute (NCI)" with 44 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Oncology Hematology Care Inc-Mercy West
According to Clinical.Site data, the most researched conditions in "Oncology Hematology Care Inc-Mercy West" are
"Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Recurrent Breast Carcinoma" (5 trials), "Recurrent Ovarian Carcinoma" (4 trials) and "Stage IIIA Breast Cancer" (4 trials). Many other conditions were trialed in "Oncology Hematology Care Inc-Mercy West" in a lesser frequency.
Clinical Trials Intervention Types at Oncology Hematology Care Inc-Mercy West
Most popular intervention types in "Oncology Hematology Care Inc-Mercy West" are "Drug" (72 trials), "Other" (60 trials), "Biological" (27 trials), "Procedure" (15 trials) and "Radiation" (7 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "Quality-of-Life Assessment" (19 trials), "Carboplatin" (12 trials), "Cisplatin" (10 trials) and "Docetaxel" (9 trials). Other intervention names were less common.
Clinical Trials Genders at Oncology Hematology Care Inc-Mercy West
The vast majority of trials in "Oncology Hematology Care Inc-Mercy West" are
65 trials for "All" genders and 15 trials for "Female" genders.
Clinical Trials Status at Oncology Hematology Care Inc-Mercy West
Currently, there are NaN active trials in "Oncology Hematology Care Inc-Mercy West".
undefined are not yet recruiting,
8 are recruiting,
46 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 22 completed trials in Oncology Hematology Care Inc-Mercy West,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Oncology Hematology Care Inc-Mercy West, 4 "Phase 1"
clinical trials were conducted, 40 "Phase 2" clinical
trials and 44 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".